Overview
Xiangmin Tong practices in Hangzhou, China. Tong is rated as an Experienced expert by MediFind in the treatment of Chronic Lymphocytic Leukemia (CLL). Their top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Liver Cancer.
Their clinical research consists of co-authoring 131 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Chronic Lymphocytic Leukemia (CLL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaTong isAdvanced. Learn about B-Cell Lymphoma.
- Experienced
- Aase SyndromeTong isExperienced. Learn about Aase Syndrome.
- Acute Myeloid Leukemia (AML)
- Burkitt LymphomaTong isExperienced. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)